OpenSAFELY Jobs

abrx_os_brit amr-uom-brit|ABRX_comparison_OS_v_brit aftershocks-health-inequalities aftershocks-notebook|combined_tests aimpaper-analysis covid-unvaccinated-aimpaper|main amr-uom-brit-main amr-uom-brit|main anticoagulant-first-run anticoagulants-research|master anticoagulant-second-run anticoagulants-research|master anticoagulant-sensitivity-analysis-5-check anticoagulants-research|SA5-check anticoagulant-third-run anticoagulants-research|master antidepressants-healthinequalities antidepressants|main antimicrobial-stewardship antimicrobial-stewardship|master antipsychotics-prescribing-during-covid-19-master antipsychotics-prescribing-during-COVID-19|master antipsychotics-prescribing-during-covid-19-sa antipsychotics-prescribing-during-COVID-19|updates benbc-test benbc-test|master blood-pressure-qof blood-pressure-qof|master breakthrough-covid-emis COVID-19-vaccine-breakthrough|EMIS breakthrough-covid-master COVID-19-vaccine-breakthrough|master breakthrough-covid-trial-pop COVID-19-vaccine-breakthrough|trial-pop breakthrough-covid-wip COVID-19-vaccine-breakthrough|wip bristol-demo os-demo-research|try-os carehome-noncarehome-death-research carehome-noncarehome-death-research|master carehomeprescribing CareHomePrescribing|main carehomes carehomes-research|master carehome-sa SA_carehomerx|main carehomes_mortality carehomes-mortality-research|master carehomes-nb-full carehomes-research|msoa-nbs carehomes-short-data-report carehomes-short-data-report|first-commit carehomes-short-data-report-main carehomes-short-data-report|master carehomes-slice carehomes-research|master carehomes-slice-nb carehomes-research|master carehomes-test carehomes-research|test carehomes-test-full carehomes-research|test cohortextractor-v2-testing-long-covid long-covid|simplified-for-ce2 comparative-ve-research_main comparative-ve-research|main covid-diabetes-outcomes covid-diabetes-outcomes|main covid-vaccine-effectiveness-research_main covid-vaccine-effectiveness-research|main covid-vaccine-effectiveness-research_positivity covid-vaccine-effectiveness-research|positivity covid-vaccine-effectiveness-research_startdate covid-vaccine-effectiveness-research|startdate covid-vaccine-neuro-research covid-vaccine-neuro-research|main covid-vaccine-not-done-branch covid-vaccine-not-received|create-outputs covid-vaccine-preliminary-study-master covid-vaccine-preliminary-study|master covid-ve-change-over-time--explore-2nd-vax-dates covid-ve-change-over-time|main covid-ve-change-over-time-main covid-ve-change-over-time|main covid-vs-non-covid-deaths-research covid-vs-noncovid-deaths-research|master database-notebooks_full_master database-notebooks|master databricks-test databricks-test|main david_ryan research-template|master dkryan research-template|master doc-test os-demo-research|master emis-qa-main emis-qa|main emis-smoke-tests emis-smoke-tests|master ethnicity-2nd-wave_master Ethnicity-2nd-wave|master ethnicity-3rd-wave ethnicity-covid-3rd-wave|master ethnicity-master ethnicity-covid-research|master ethnicity-short-data-report ethnicity-short-data-report|main ethnicity-short-data-report-test ethnicity-short-data-report|write-study-def flu-vacc-research-nov flu-vacc-research|october-update generate_cohort anticoagulants-research|master germdefence GermDefence|main ghickman-testing gh-testing-research|master group-video-consultation OS_VidGroupClinic_v001-research|snomed-version hba1c-levels HbA1c-levels|study-def hba1c-levels-report HbA1c-levels|master hest_os_study HEST_OS_study|main hh-classification-research hh-classification-research|master highcostdrugs_adalimumab_master highcostdrugs-research|master highcostdrugs_adalimumab_v2_full highcostdrugs-research|study_def highcostdrugs_v3 highcostdrugs-research|hcd_analysis hospital-admissions-validation vaccine-effectiveness-hospital-admissions-validation|secondary households households-research|master households-short-report households-short-data-report|main imd imd-breakdown|master immunosuppressant-meds-research immunosuppressant-meds-research|master immunosuppressant-meds-research_v2 immunosuppressant-meds-research|Update_StudyDef initial_run HEST_OS_study|study_definition_edit learning-disabilities absolute-risks-covid-research|master learning-disabilities-full absolute-risks-covid-research|master long-covid-descriptive long-covid-descriptive-research|main long-covid-emis long-covid|EMIS long-covid-historical-health long-covid-historical-health|main long-covid-ncs long-covid|NCS-historical-health long-covid-sick-notes long-covid-sick-notes|master mechanical-valve-anticoag mechanical-valve-anticoag|master mechanical-valve-anticoag-updated mechanical-valve-anticoag|updates med-safety-poc med-safety-PoC|main millie_test os-demo-research|master ncs-hospital-disruption hospital-disruption-research|master ncs-hospital-disruption-2 hospital-disruption-research|icd-10-fix nhsdtre_replication post-covid-bristol|main online_consultation OS_OC_v001-research|master online-consultations-emis OS_OC_v001-research|emis-branch onlineconsultations_run01 OS_OC_v001-research|mf-edit-23Mar onlineconsultations_run01_cutdown OS_OC_v001-research|mf-edit-23Mar os-demo-research os-demo-research|master os-sch-children-2021 os-sch-children-2021|main paper_revision_oral_anticoagulant oral-anticoagulant-covid-outcome|main pathology-comparators-main pathology-comparators-short-report|master pincer-measures pincer-measures|main pincer-measures-change-detection pincer-measures-change-detection|main population-csvt-counts population-outcomes-burden-research|CSVT population-outcomes-burden population-outcomes-burden-research|master post-admissions-admissions-kb post-admission-admissions-research|master post-admissions-admissions-testarea post-admission-admissions-research|master post-covid-competing-risks post-covid-outcomes-research|reviewer-updates post_covid_nice_compliance Post_covid_nice_compliance|master post-covid-research post-covid-outcomes-research|master post-covid-thrombosis post-covid-thrombosis-research|master post-covid-unvaccinated post-covid-unvaccinated|main post-covid-vaccinated post-covid-vaccinated|main post-vax-ae-attendance_main post-vax-ae-attendance|main post-vax-outcomes-report_main post-vax-outcomes-report|master primary-care-covid-codes-research primary-care-covid-codes-research|master primis-codelist-prevalence primis-codelist-prevalence|master primis-covid19-vaccine-uptake-0 primis-covid19-vaccine-uptake|master principle_trial_budesonide_inhalers_main principle-inhaler-uptake|main prostate_cancer_psa_testing_2021 PSA2021|main pulse_oximetry_sro SRO-PULSE-OXIMETRY-UPD|master rct-test rct-test|main reinfection reinfection|master release-testing release-process-test|main restoration-observatory-emis-research restoration-observatory-emis-research|JPearson_MMR restoration-observatory-emis-tpp-test restoration-observatory-emis-research|notebooks risk-prediction risk-prediction-research|master school-age-children school-age-children-and-covid|master school-age-children-2 school-age-children-and-covid2|master second-line-diabetes-covid-research second-line-diabetes-covid-research|master service_restoration_observatory aftershocks-notebook|master sgtf-cfr-research SGTF-CFR-research|master sgtf-omi SGTF-Omi-research|main sro-blood-tests SRO-Measures|blood-tests sro-gastro sro-gastro|main sro-gastro-cut-down sro-gastro|main sro-measure-cam-test opensafely-SRO-Measures|graphnet sro-measure-dev-test opensafely-SRO-Measures|graphnet sro-measures SRO-Measures|master sro-measures-cam-poc opensafely-SRO-Measures|graphnet sro-measures-demographics SRO-Measures|demographics-notebook sro-measures-emis SRO-Measures|emis sro-measures-gn-test opensafely-SRO-Measures|graphnet sro-pulse-oximetry SRO-pulse-oximetry|master sro-pulse-oximetry-2 SRO-pulse-oximetry|template sro-smr SRO-smr|master sro-smr-codelists SRO-smr|codelist-counts surgery-outcomes-full surgery-research|master t1dm_covid_research T1DM_covid_research|master t1dm_covid_sample T1DM_covid_research|python-matching t1dm_post_covid T1DM_covid_research|master test-master COVID-19-vaccine-breakthrough|master the_effects_of_covid-19_on_doac_prescribing doacs-covid19|main tncc_ve tncc_ve|main tpp_representativeness representativeness|master updates-november COVID-19-vaccine-breakthrough|updates-november vaccine-characteristics-research vaccine-characteristics-research|master vaccine-effectiveness-hospital-admissions-validation vaccine-effectiveness-hospital-admissions-validation|master vaccine-eligibility vaccine-eligibility|will-run vaccine_eligibility_master vaccine-eligibility|master vaccine-rd vaccine-rd-research|main